Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Copovidone (PVP-VA) Market Growth Potential: How Will Market Size Shift Through 2030?
The copovidone (PVP-VA) market has seen substantial growth in recent years. Projections indicate it will expand from $1.08 billion in 2025 to $1.18 billion in 2026, at a compound annual growth rate (CAGR) of 9.3%. The historical expansion can be ascribed to several factors, such as the increasing demand for oral solid dosage drugs and generics, the growing necessity for solubility enhancers for active ingredients that are poorly water-soluble, the rising development of advanced drug-delivery systems that require high-performance binders, and the expanding utilization of copovidone in film-coated and controlled-release formulations.
The copovidone (PVP-VA) market size is projected to experience robust expansion over the coming years, with its value expected to reach $1.67 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 9.1%. This anticipated growth is primarily fueled by the increasing adoption of versatile polymers in cosmetics and personal-care formulations, a rising demand for multifunctional excipients in food, nutraceutical, and industrial applications, enhanced regulatory acceptance and quality standards favoring copovidone, and growing investments in novel formulations that utilize copovidone. Significant trends identified for this period encompass advancements in using copovidone for poorly water-soluble drugs through hot-melt extrusion and spray-drying techniques, innovations in controlled-release and solvent-free drug formulations, the integration of copovidone into nutraceutical and cosmeceutical products, progress in regulatory harmonization to streamline global distribution, and the development of innovative multifunctional excipient blends combining copovidone with other polymers.
Get A Free Sample Report With In-Depth Market Insights:
Copovidone (PVP-VA) Market Growth Backed By Core Demand Fundamentals
The increasing need for biopharmaceuticals is projected to boost the expansion of the copovidone (PVP-VA) market. These are therapeutic agents developed from biological origins or through biotechnological processes, differing from conventional chemical production. The escalating requirement for biopharmaceuticals stems from the growing incidence of chronic and intricate illnesses, necessitating sophisticated targeted treatments that traditional medications often cannot address adequately. Copovidone (PVP-VA) aids this biopharmaceutical demand through its adaptable formulation and stabilizing characteristics, rendering it suitable for cutting-edge drug delivery systems. It improves drug solubility, stability, and bioavailability, thereby boosting overall therapeutic efficacy and facilitating the development of novel biopharmaceutical products. As an illustration, in June 2025, data from the US-based federal agency, the Centers for Medicare & Medicaid Services (CMS), showed that spending on prescription drugs increased by 11.4% in 2023, reaching $449.7 billion, a rise from the 7.8% growth observed in 2022. Consequently, the expanding demand for biopharmaceuticals is fueling the growth of the copovidone (PVP-VA) market.
Copovidone (PVP-VA) Market Segment Analysis: What Are The Core Market Categories?
The copovidone (pvp-va) market covered in this report is segmented –
1) By Type: Copovidone, PVP-VA 64, PVP-VA 73
2) By Product Form: Powder, Liquid
3) By Application: Pharmaceuticals, Cosmetics, Food And Beverage, Adhesives, Coatings
4) By Distribution Channel: Direct Sales, Distributors, Online Retailers
Subsegments:
1) By Copovidone: Direct Compression Grade, Wet Granulation Grade, Film-Forming Grade, Sustained-Release Applications, Immediate-Release Applications
2) By PVP-VA 64: Tablet Binding Applications, Film-Coating Applications, Granulation Applications, Solubility-Enhancement Uses, Hot-Melt Extrusion Applications
3) By PVP-VA 73: High-Viscosity Formulations, Controlled-Release Systems, Solid Dispersion Formulations, Capsule Filling Applications, Stabilization Of Active Ingredients
Copovidone (PVP-VA) Market Growth Trends Reshaping The Competitive Landscape
Companies active in the copovidone (PVP-VA) market are concentrating on introducing sophisticated product grades and services, such as nitrite-tested grades, to improve regulatory compliance, enhance drug safety, and decrease the potential for nitrosamines. Nitrite-tested grades refer to advanced quality assurance provisions for excipients where every delivered batch undergoes testing for nitrites, a possible precursor to nitrosamines, with the findings recorded on the Certificate of Analysis. For example, in August 2025, BASF SE, a German chemical and materials firm, introduced Kollidon Nitrite Tested (NT) grades. This is an advanced service tier intended to support customers’ nitrosamine control strategies through improved nitrite testing and documentation for important products, including Kollidon VA 64 NT. The service ensures nitrite tests are conducted according to the respective product specification, with results documented on the Certificate of Analysis (CoA) for all batches provided, thereby offering an additional level of quality assurance and documentation.
Copovidone (PVP-VA) Market Competitive Overview And Top Companies
Major companies operating in the copovidone (pvp-va) market are BASF SE, Ashland Global Holdings Inc., Hangzhou Motto Science & Technology Co. Ltd., JRS Pharma GmbH & Co. KG, Boai NKY Pharmaceuticals Ltd., Anhui Sunhere Pharmaceutical Excipients Co. Ltd., Luxi Group Co. Ltd., Zhongbao Chemicals Co. Ltd., Autech Industry Co. Ltd., Huangshan Bonsun Pharmaceuticals Co. Ltd., Ningbo Inno Pharmchem Co. Ltd., Shanghai Yuking Water Soluble Material Technology Co. Ltd., Tianjin YR Chemspec Technology Co. Ltd., Star-Tech Specialty Products Co. Ltd., JH Nanhang Life Sciences Co. Ltd., Huzhou Sunflower Specialty Polymer Co. Ltd., Jiaozuo Zhongwei Special Products Pharmaceutical Co. Ltd., Ulanqab Kema New Material Co. Ltd., Sunfair PCS Polymer Material (Nanjing) Co. Ltd., Hefei Trendchem Co. Ltd.
View The Full Copovidone (PVP-VA) Market Report:
Copovidone (PVP-VA) Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the copovidone (PVP-VA) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the copovidone (pvp-va) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
